KENYON LAWRENCE A 4
4 · Outlook Therapeutics, Inc. · Filed Oct 5, 2020
Insider Transaction Report
Form 4
KENYON LAWRENCE A
CFO and Secretary
Transactions
- Award
Stock Option (Right to Buy)
2020-10-01+3,668,984→ 3,668,984 totalExercise: $0.71Exp: 2030-10-01→ Common Stock (3,668,984 underlying)
Footnotes (1)
- [F1]The options were granted under the Issuer's 2015 Equity Incentive Plan (the "2015 Plan") and shall vest in four equal installments beginning on October 1, 2021 such that the option shall be vested in full on October 1, 2024, subject to the Reporting Person providing continuous service to the Issuer on each such date, and subject to acceleration upon a Change in Control as defined in the 2015 Plan, subject to the Reporting Person providing continuous service to the Issuer through such event.